<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>University of Qom</PublisherName>
				<JournalTitle>Advances in Energy and Materials Research</JournalTitle>
				<Issn>3041-8836</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2024</Year>
					<Month>03</Month>
					<Day>27</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Identification of inhibitors of SARS-Cov-2 -S protein and human ACE2 interaction based on secondary metabolites from Rose water: molecular docking approach.</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>4</FirstPage>
			<LastPage>11</LastPage>
			<ELocationID EIdType="pii">3271</ELocationID>
			
<ELocationID EIdType="doi">10.22091/jaem.2023.9619.1002</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Hourieh</FirstName>
					<LastName>Kalhor</LastName>
<Affiliation>Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0003-0715-294X</Identifier>

</Author>
<Author>
					<FirstName>Mohaddeseh</FirstName>
					<LastName>Taleghani</LastName>
<Affiliation>Department of Chemistry, Faculty of Science, University of Qom, Qom, Iran</Affiliation>
<Identifier Source="ORCID">0009-0007-3146-1968</Identifier>

</Author>
<Author>
					<FirstName>Ebrahim</FirstName>
					<LastName>Honarmand</LastName>
<Affiliation>Department of Chemistry, Faculty of Science, University of Qom, Qom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-6854-781X</Identifier>

</Author>
<Author>
					<FirstName>Reza</FirstName>
					<LastName>Safari</LastName>
<Affiliation>Department of Chemistry, Faculty of Science, University of Qom, Qom, Iran</Affiliation>
<Identifier Source="ORCID">0000-0001-6623-2080</Identifier>

</Author>
<Author>
					<FirstName>Maryam</FirstName>
					<LastName>Khayat Kashani</LastName>
<Affiliation>PHD of analytical chemistry, tuba-faculty traditional medicine</Affiliation>
<Identifier Source="ORCID">0000-0003-0462-7209</Identifier>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2023</Year>
					<Month>10</Month>
					<Day>07</Day>
				</PubDate>
			</History>
		<Abstract>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new member of the Betacoronavirus family that has led to a pandemic in g recent years. It is well documented that the Receptor Binding Domain (RBD) of the S protein (spike glycoprotein) of SARS-CoV-2 binds to the human Angiotensin-Converting Enzyme 2 (ACE2) receptor to entry lower respiratory tract epithelial cells. Thus, inhibition of SARS-CoV-2-RBD/ACE2 interactions present an interesting research challenge. In this study, molecular docking approaches were applied to identify compounds from Rose water secondary metabolites againstSARA-CoV2. Subsequently, several Rose water secondary metabolites from Rose water were identified, that had the highest percentages of Rose water, including: Eugenol, Alpha-terpineol, Geraniol, Citronellol, Phenylethyl alcohol, Nerol, and Linalool. Autodock vina software was used to perform docking between selected secondary metabolites and ACE2 binding site of SARS-CoV-2 -RBD. The docking results were analyzed based on the binding affinity, binding modes, and physicochemical properties. The results indicated that all selected secondary metabolites could bind to RBD; however, Eugenol had the highest binding affinity (-6.0 kcal/mol) compared to Alpha-terpineol (--5.7 kcal/mol), Geraniol (-5.3 kcal/mol), Phenylethyl alcohol (-5.3 kcal/mol), Citronellol (-4.6 kcal/mol), Nerol (-4.4 kcal/mol), and Linalool (-4.3 kcal/mol). Our Computer Aid Drug Design approach may contribute to the development of new drugs against SARS-CoV-2. However, the effect of these secondary metabolites needs to evaluated in in vitro, in vivo.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">SARS-CoV-2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">ACE2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">S protein</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">molecular docking</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Rose water</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://jaem.qom.ac.ir/article_3271_b6969f8e2f416ee3252e0a486f2bbef2.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
